IDiyas

For the Inventor, By the Inventor

Saitama-ken, Japan

Koichiro Yamada

USPTO Granted Patents = 14

Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 118(Granted Patents)


Location History:

  • Kawaguchi, JP (1989)
  • Saitama, JP (1993 - 1995)
  • Minamisaitama-gun, JP (1998)
  • Shiraoka-machi, JP (1998)
  • Saitama-ken, JP (1996 - 2007)

Company Filing History:

goldMedal13 out of 324 
 
Tanabe Seiyaku Company, Limited
 patents
silverMedal1 out of 1 
 
Tanabe Seiyaky Co., Ltd.
 patent

Years Active: 1989-2007

Loading Chart...
14 patents (USPTO):Explore Patents
1. 7273868 - Pyrazine derivatives (2007-09-25),
2. 7220736 - Pyrimidine compounds (2007-05-22),
3. 7078522 - Pyridopyrimidine or naphthyridine derivative (2006-07-18),
4. 6797709 - Aromatic nitrogen-containing 6-membered cyclic compounds (2004-09-28),
5. 6656935 - Aromatic nitrogen-containing 6-membered cyclic compounds (2003-12-02),
6. 6395741 - Agent for prophylaxis or treatment of dysuria (2002-05-28),
7. 5807883 - 2-oxoindoline derivative (1998-09-15),
8. 5739333 - Sulfonamide derivative and process for preparing the same (1998-04-14),
9. 5728706 - Benzenesulfonamide derivative and process for preparing thereof (1998-03-17),
10. 5589478 - Benzenesulfonamide derivative and process for preparing thereof (1996-12-31),
11. 5434148 - .beta.-carboline derivative (1995-07-18),
12. 5332754 - Naphthyloxazolidone derivatives (1994-07-26),
13. 5182296 - Naphthyloxazolidone derivatives (1993-01-26),
14. 4839360 - Lactam derivatives (1989-06-13),

Title: The Innovations of Inventor Koichiro Yamada

Introduction

Koichiro Yamada is a prolific inventor based in Saitama-ken, Japan, renowned for his significant contributions to the field of pharmacology through his innovative compounds. With a remarkable portfolio that includes 14 patents, Yamada has made notable advancements in medicinal chemistry, particularly in the development of compounds with therapeutic potential.

Latest Patents

Yamada's latest patents showcase his expertise in designing novel pharmacologically active compounds. One of his breakthroughs includes pyrazine derivatives, specifically a cyclic compound of the formula (I) or its pharmacologically acceptable salts. In addition, his work with pyrimidine compounds has yielded a cyclic compound of the formula (I) with significant selective PDE V inhibitory activity. This activity is crucial as it offers therapeutic or prophylactic solutions for treating various diseases linked to functional disorders in cGMP-signaling.

Career Highlights

Throughout his career, Koichiro Yamada has worked with esteemed organizations, notably Tanabe Seiyaku Company, Limited, and Tanabe Seiyaku Co., Ltd. His tenure in these companies has played a vital role in fostering his innovative spirit and advancing his research capabilities.

Collaborations

Yamada’s accomplishments are further amplified by his collaborations with talented colleagues, including Kohei Kikkawa and Kenji Omori. Their collective efforts in research have contributed to the successful development of numerous patents, enhancing the scope of pharmacological inventions.

Conclusion

In summary, Koichiro Yamada stands out as a leading inventor in the field of pharmacology, with a strong focus on creating compounds that address critical health issues. His ongoing dedication to innovation and collaboration continues to inspire advancements in therapeutic science, paving the way for new treatments and improved health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…